Medical Research Council Integrative Epidemiology Unit, University of Bristol, Bristol, United Kingdom.
School of Social and Community Medicine, University of Bristol, Bristol, United Kingdom.
Biol Psychiatry. 2016 Apr 1;79(7):549-56. doi: 10.1016/j.biopsych.2015.08.001. Epub 2015 Aug 12.
Associations between cannabis use and psychotic outcomes are consistently reported, but establishing causality from observational designs can be problematic. We review the evidence from longitudinal studies that have examined this relationship and discuss the epidemiologic evidence for and against interpreting the findings as causal. We also review the evidence identifying groups at particularly high risk of developing psychosis from using cannabis. Overall, evidence from epidemiologic studies provides strong enough evidence to warrant a public health message that cannabis use can increase the risk of psychotic disorders. However, further studies are required to determine the magnitude of this effect, to determine the effect of different strains of cannabis on risk, and to identify high-risk groups particularly susceptible to the effects of cannabis on psychosis. We also discuss complementary epidemiologic methods that can help address these questions.
大麻使用与精神病发病结果之间存在一致关联,但从观察性设计中确定因果关系可能存在问题。我们综述了纵向研究中检验该关联的证据,并讨论了将这些发现解释为因果关系的流行病学证据。我们还综述了确定使用大麻后精神病发病风险特别高的人群的证据。总体而言,来自流行病学研究的证据足以提供有力证据,值得发出公共卫生信息,即大麻使用会增加精神病发病的风险。然而,需要进一步的研究来确定这种效应的程度,确定不同大麻菌株对风险的影响,并确定特别容易受到大麻对精神病影响的高危人群。我们还讨论了有助于解决这些问题的补充流行病学方法。